Logo

American Heart Association

  163
  0


Final ID: Su1026

The Polygenic Mechanisms of Dilated Cardiomyopathy Contribute to The Development of Tachycardia-Associated Cardiomyopathy in Patients With Atrial Tachyarrhythmias

Abstract Body (Do not enter title and authors here): Background
Longstanding tachycardia can lead to reversible left ventricular (LV) systolic dysfunction called tachycardia-associated cardiomyopathy (TAC). It is unknown if there is a genetic predisposition to the development of TAC or whether there is overlap between the genetic pathways of TAC and dilated cardiomyopathy (DCM).

Research Questions
Is there a genetic predisposition towards the development of TAC in individuals with arrhythmia? If so, do these genetic pathways overlap with those of DCM?

Methods/Approach
The study is a single-center case control study performed at the Montreal Heart Institute (MHI). Inclusion criteria for TAC cases are shown in Table 1. All cases underwent array genotyping and exome sequencing. Previously genotyped controls with arrhythmia but no documented LV dysfunction were included from the MHI Biobank. Following imputation using the TOPMed imputation server, a polygenic score for DCM (PGSDCM; PGS000666) was calculated for cases and controls. The rate of (likely) pathogenic variants in known cardiomyopathy genes was reported in cases.

Results/Data (descriptive and inferential statistics)
The study included 107 cases and 878 controls. Case characteristics are shown in Table 1. The average PGSDCM for cases was significantly higher than that of controls (p-value <10-10; Figure 1). Logistic regression with correction for age, sex, and ancestry (principal components) showed a strong association of PGSDCM with TAC (OR 1.99, 95% CI 1.54-2.58; p-value <10-6). Notably, among patients with atrial tachyarrhythmias, those with a PGSDCM above the 95th percentile had a 3.53-fold increased risk of TAC (p-value 4.5-4). Exome sequencing in TAC cases identified only 2/107 (2%) carriers of (likely) pathogenic variants (in cardiomyopathy genes TNNT2 and MYH7).

Conclusions
Pathogenic variants account for a small minority of TAC cases. In contrast, a significant association between PGSDCM and TAC is suggestive of a shared polygenic pathway between TAC and DCM.
  • Safabakhsh, Sina  ( University of British Columbia , Vancouver , British Columbia , Canada )
  • Raymond-paquin, Alexandre  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Jordà, Paloma  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Grondin, Steffany  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Parker, Jeremy  ( University of British Columbia , Vancouver , British Columbia , Canada )
  • Fazeli, Amir  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Castillo, Ismael  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Laksman, Zachary  ( University of British Columbia , Vancouver , British Columbia , Canada )
  • Tardif, Jean-claude  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Tadros, Rafik  ( Montreal Heart Institute , Montreal , Quebec , Canada )
  • Author Disclosures:
    Sina Safabakhsh: DO NOT have relevant financial relationships | Alexandre Raymond-Paquin: No Answer | Paloma Jordà: DO NOT have relevant financial relationships | Steffany Grondin: No Answer | Jeremy Parker: DO NOT have relevant financial relationships | Amir Fazeli: DO NOT have relevant financial relationships | Ismael Castillo: No Answer | Zachary Laksman: DO NOT have relevant financial relationships | Jean-Claude Tardif: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amarin:Past (completed) ; Research Funding (PI or named investigator):Boeringher-Ingelheim:Active (exists now) ; Research Funding (PI or named investigator):Novo-Nordisk:Active (exists now) ; Consultant:DalCor Pharmaceuticals:Active (exists now) ; Ownership Interest:DalCor Pharmaceuticals:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Speaker:Pendopharm:Past (completed) ; Speaker:HLS Pharmaceuticals:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) ; Research Funding (PI or named investigator):Merck:Active (exists now) ; Research Funding (PI or named investigator):Esperion:Active (exists now) ; Research Funding (PI or named investigator):DalCor Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):Ceapro:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) | Rafik Tadros: DO have relevant financial relationships ; Research Funding (PI or named investigator):BMS Canada:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Polygenic Risk Profiling in Multi-Ethnic Populations

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Coronary Artery Disease Polygenic Risk Scores with Equivalent Performance Produce Discordant Estimates of Individual Risk

Abramowitz Sarah, Voight Benjamin, Pasaniuc Bogdan, Levin Michael, Damrauer Scott, Boulier Kristin, Keat Karl, Cardone Katie, Shivakumar Manu, Depaolo John, Judy Renae, Kim Dokyoon, Ritchie Marylyn

4-Hydroxy-2-Nonenal Alters Alternative Polyadenylation to Regulate mRNA Isoform Diversity in the Transition from Human Cardiac Fibroblasts to Myofibroblasts

Natarajan Kartiga, Neupane Rahul, Yalamanchili Hari Krishna, Palaniyandi Suresh, Wagner Eric, Guha Ashrith, Amirthalingam Thandavarayan Rajarajan

More abstracts from these authors:
Polygenic score analyses in a large multinational HCM clinical cohort identifies effects on disease penetrance and severity

Jorda Paloma, Michels Michelle, Christiaans Imke, Paterson Natasha, Houweling Arjan, Tremblay-gravel Maxime, Garceau Patrick, Lallier Philippe, Khan Habib, Roston Thomas, Steinberg Christian, Lipov Alex, Olivotto Iacopo, Barriales Roberto, Jurgens Sean, Cadrin-tourigny Julia, Tanck Michael, Amin A.s., Adler Arnon, Tadros Rafik, Bezzina Connie, Gimeno Blanes Juan Ramon, Castillo Ismael, Walsh Roddy, Poel Edwin, Moussa Samuel, Haydarlou Poeya, Baas Annette

AI biomarkers in the era of multimodality imaging and their role in clinical discovery

Tardif Jean-claude, Dweck Marc

You have to be authorized to contact abstract author. Please, Login
Not Available